Levobupivacaine: A new safer long acting local anaesthetic agent

Expert Opinion on Investigational Drugs

Volumn 8, Issue 6, 1999, Pages 861-876

  Gristwood, R W ^a   Greaves, J L ^a  

^a ST JOHN S COLLEGE   (United Kingdom)

Author keywords

Cardiotoxicity; Enantiomer; Levobupivacaine; Long acting local anaesthetic; Nerve blockade; S bupivacaine; Safety profile

Indexed keywords

BUPIVACAINE; CALCIUM CHANNEL; LEVOBUPIVACAINE; LEVOBUVICAINE; LOCAL ANESTHETIC AGENT; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANALGESIA; AREA UNDER THE CURVE; BRACHIAL PLEXUS ANESTHESIA; CARDIOTOXICITY; CESAREAN SECTION; CLINICAL TRIAL; CONVULSION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; ENANTIOMER; EPIDURAL DRUG ADMINISTRATION; HEART CONTRACTION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NERVE BLOCK; NEUROTOXICITY; PERIPHERAL NERVE; POSTOPERATIVE PAIN; QT INTERVAL; REVIEW; ULNAR NERVE;

EID: 0033052870     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.6.861     Document Type: Review

References (57)